StoneX Group’s Health Catalyst HCAT Stock Holding History

StoneX Group’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.5K	Buy	+10,492	New	+$20K	﹤0.01%	1761

Other funds holding HCAT

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Williams & Novak Westlake Village, California $169M AUM 17.63% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Signal Advisors Wealth Detroit, Michigan $2.27B AUM 16.1% 1-Year Est. Return

Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $770M AUM 34.25% 1-Year Est. Return

GC Wealth Management RIA Cambridge, Massachusetts $2.08B AUM 16.73% 1-Year Est. Return

StoneX Group's HCAT Position: Q3 2026 in Review

StoneX Group opened a new position in Health Catalyst (HCAT) in Q3 2026: 10,492 shares worth $19.5K. The stake represents ﹤0.01% of the portfolio and ranks #1761 among its holdings.

22 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

StoneX Group held 10,492 shares of Health Catalyst worth $19.5K as of Q3 2026.
Health Catalyst was a new StoneX Group position in Q3 2026.
Health Catalyst made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1761 holding.
22 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.